RIL
TCRT icon

Rothschild Investment LLC’s Alaunos Therapeutics TCRT Stock Holding History

Rothschild Investment LLC’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-98
Closed -$81K – 492
2016
Q2 		$81K Buy
98
+25
+34% +$27.2K 0.01% 466
2016
Q1 		$82K Buy
73
+1
+1% +$1.02K 0.01% 460
2015
Q4 		$89K Buy
+72
New +$119K 0.01% 466

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rothschild Investment LLC's TCRT Position: Q3 2016 in Review

Rothschild Investment LLC sold out of Alaunos Therapeutics (TCRT) in Q3 2016, closing a stake of 98 shares — an estimated $81K sold.

Rothschild Investment LLC first reported a position in TCRT in Q4 2015 and held it in 3 quarters. The position peaked at $89K in Q4 2015. 140 funds tracked by Wall St. Rank hold TCRT as of Q3 2016.

  • Rothschild Investment LLC reported no remaining Alaunos Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Rothschild Investment LLC sold 98 Alaunos Therapeutics shares in Q3 2016, an estimated $81K.
  • Rothschild Investment LLC first reported a position in Alaunos Therapeutics in Q4 2015 and held it in 3 quarters.
  • Rothschild Investment LLC's Alaunos Therapeutics position peaked at $89K in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2016.

Based on Rothschild Investment LLC's 13F filing for Q3 2016, filed 18 Oct 2016.